BCM
TMO icon

Brainard Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Brainard Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$262K Hold
455
– – 0.2% 59
2022
Q4 		$251K Buy
+455
New +$241K 0.21% 73

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Brainard Capital Management's TMO Position: Q1 2023 in Review

Brainard Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q1 2023 at 455 shares worth $262K. The position accounts for 0.2% of the portfolio, ranked #59.

Brainard Capital Management first reported a position in TMO in Q4 2022 and has held it in 2 quarters since. 2,387 funds tracked by Wall St. Rank hold TMO as of Q1 2023.

  • Brainard Capital Management held 455 shares of Thermo Fisher Scientific worth $262K as of Q1 2023.
  • Brainard Capital Management left its Thermo Fisher Scientific share count unchanged in Q1 2023.
  • Thermo Fisher Scientific made up 0.2% of Brainard Capital Management's portfolio in Q1 2023, its #59 holding.
  • Brainard Capital Management first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 2 quarters since.
  • 2,387 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.

Based on Brainard Capital Management's 13F filing for Q1 2023, filed 9 May 2023.